Rupali J. Limaye

Rupali J. Limaye

Auto-generated profile, based on publicly available information

Rupali J. Limaye

Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA; Department of Global and Community Health, College of Public Health, George Mason University, 4400 University Drive, Fairfax, Virginia 22020, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
ERErica Rosser
Erica Rosser
MWMegan D. Wysong
Megan D. Wysong
JRJoseph Gregory Rosen
Joseph Gregory Rosen
RLRupali J. Limaye
Rupali J. Limaye
SPSoim Park
Soim Park
Background/Objectives: Low- and middle-income countries (LMICs) have the highest global burden of cervical cancer deaths. Human papillomavirus (HPV) vaccination is a key strategy for cervical cancer elimination, and in LMICs, global recommendations to vaccinate girls aged 9–14 years against HPV are generally implemented through school-based immunization platforms. Unfortunately, this strategy risks missing out-of-school (OOS) girls (i.e., girls not enrolled in formal schools). This narrative review maps the literature and synthesizes existing evidence on service delivery strategies for reaching OOS girls with HPV vaccination in LMICs. Methods: Using relevant databases, we conducted a narrative review of published, peer-reviewed literature to map and synthesize the existing evidence on effective service delivery strategies for reaching OOS girls with HPV vaccination in LMICs. Results: The 21 articles identified presented findings on strategies to reach OOS girls, with the most frequently cited strategies being facility-based and community outreach approaches. Authors also described community-based strategies used to identify and enumerate OOS girls, including peer tracing, church outreach initiatives, as well as partnerships with local groups (e.g., civil service organizations) and individuals (e.g., healthcare workers, teachers). The articles discussed barriers at the individual (e.g., lack of parental consent), facility/program delivery (e.g., lack of transportation for vaccines), and community (e.g., distance from homes to vaccination services) levels to HPV vaccine delivery, as well as solutions at the facility/program delivery (e.g., pilot programs) and community (e.g., multi-level partnerships) levels. Conclusions: Additional research is needed to evaluate implementation strategies targeting OOS girls with HPV vaccination. A better understanding of these strategies can provide valuable insights for HPV vaccine policymakers, healthcare providers, and program implementers.


30 May 2026 in Vaccine
Verified
Journal Article
Open access
VMVaishnavi Mathur
Vaishnavi Mathur
JSJessica L. Schue
Jessica L. Schue
BFBerhaun Fesshaye
Berhaun Fesshaye
PSPrachi Singh
Prachi Singh
EMEmily S. Miller
Emily S. Miller
RLRupali J. Limaye
Rupali J. Limaye
Maternal immunization provides essential maternal and fetal protection for several infectious diseases. The variability in vaccination guidelines for pregnant women across countries and through the course of the COVID-19 pandemic influenced the perception of both the general public and broader health care systems towards COVID-19 vaccination in pregnancy and moreover shaped the accessibility and decision-making trajectory of pregnant women to become fully vaccinated. As part of a larger multi-country, mixed-methods study, the purpose of this cross-sectional analysis is to assess what factors are associated with pregnant women being fully vaccinated for COVID-19 in Brazil, Ghana, Kenya, and Pakistan. In each country, participants were recruited from maternity hospitals and/or clinics which are representative of diverse socioeconomic and geographical strata. Data collection included cross-sectional surveys of 1,603 pregnant women and collected sociodemographic determinants of vaccine uptake along with personal COVID-19 vaccination decision-making experiences. This sub-analysis included 1,025 respondents who had ever received a COVID-19 vaccine. Adjusted regression models revealed that pregnant women who were able to choose their vaccine brand, were of older age, those with a partner, and those with a higher education level had higher odds of being fully vaccinated (defined as having the recommended dose number by country and brand). This analysis emphasizes the importance of countries providing clear, timely, and current immunization guidelines and resources for pregnant women, to ensure they are consistently educated and positively influenced to complete vaccination series for relevant infectious diseases to decrease related maternal and fetal morbidity and mortality.